Form 4: Standex Director Granted Restricted Stock

Standex International Director Robin J Davenport received a grant of 639 shares of common stock as restricted stock, vesting in three years.

Summary

• Robin J Davenport, a Director of Standex International Corporation, was granted 639 shares of common stock.
• The grant was made on October 21, 2025, at a price of $0 per share, indicating it was an award rather than a purchase.
• These shares are restricted stock, issued under the Company's 2018 Incentive Plan.
• The granted shares will vest three years after the date of grant, specifically on October 21, 2028.
• Following this transaction, Ms. Davenport directly beneficially owns 4,698.089 shares of Standex International common stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is a positive signal for aligning interests and retaining talent, reflecting a standard and expected compensation practice. It doesn't indicate any immediate financial distress or exceptional performance, but rather a stable operational aspect.

Positives

• The grant of restricted stock aligns the director's interests with those of long-term shareholders, as the value of the compensation is directly tied to the company's stock performance.
• This is a standard component of executive and director compensation, indicating ongoing commitment and serving as a retention incentive for key personnel.

Future Outlook

The grant of restricted stock, vesting in three years, implies an expectation of continued service from the director and a long-term focus on shareholder value creation.

Industry Context

The use of restricted stock grants as a form of compensation for directors is a common practice across various industries, including manufacturing and diversified industrial companies like Standex International. This method is widely adopted to incentivize long-term performance and align leadership interests with shareholder returns.

Comparison to Industry Standards

• Restricted stock grants are a standard component of director compensation packages in publicly traded companies, comparable to practices at peers such as Dover Corporation (DOV) or Illinois Tool Works (ITW), which also utilize equity-based incentives to retain and motivate key personnel.
• The three-year vesting period is a common structure for such grants, designed to encourage long-term commitment and performance, aligning with best practices in corporate governance and compensation.

Corporate Governance

Related Party Transactions

• The grant of restricted stock to Director Robin J Davenport is a related party transaction, as it involves compensation provided by the company to a member of its board of directors. This is a standard and disclosed practice under the company's 2018 Incentive Plan.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with long-term shareholder value, as the stock's value is tied to company performance. It also represents a minor dilution of existing shares, which is typical for equity compensation plans.
• Employees: No direct impact on general employees is indicated, but it reinforces the company's commitment to equity-based compensation for key personnel.
• Management: Reinforces the compensation structure for directors, potentially influencing retention and motivation.

Next Steps

• The restricted stock granted on October 21, 2025, will vest three years from the grant date.

Key Dates

Recommendation

This Form 4 filing reports a routine restricted stock grant to a director, which is a standard compensation practice aimed at aligning interests. It does not provide new material information that would fundamentally alter the investment thesis for Standex International. Therefore, a 'hold' recommendation is appropriate, as the filing neither presents significant positive catalysts nor negative concerns that would warrant a change in investment position based solely on this information.

Keywords

Standex International, SXI, Robin J Davenport, Restricted Stock, Stock Grant, Director Compensation, SEC Form 4, Insider Transaction, Equity Incentive Plan